
Oppenheimer downgrades Insulet despite strong Q2 earnings and revenue growth.
Oppenheimer downgraded Insulet Corporation from Outperform to Perform following the company's strong Q2 earnings report, which showed 23% revenue growth and improved profitability metrics. Despite the solid quarterly results driven by demand for its ...


